← Open Payments lookup

ADAM DANNEHL: Open Payments

NPI 1073066304 · LEXINGTON, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$379 in 12 payments from 5 companies in 2025. Trend: 2023 $150 · 2024 $476 · 2025 $379

Food & beverage: $379
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$232
Novo Nordisk Inc5$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$32
Lilly USA, LLC1$18
ANI Pharmaceuticals, Inc.1$17

Products named: FARXIGA, Rybelsus, XIFAXAN, Ozempic, AIRSUPRA, BREZTRI, MOUNJARO, PURIFIED CORTROPHIN GEL.

Industry payments across NE — which companies pay providers there.